Life Sciences Focused Articles

Product regulation and liability in Mexico

Apr – 18 – 2018

Impact of the “Comprehensive and Progressive Agreement for Trans-Pacific Partnership” on Life Sciences in Mexico

Mar – 28 – 2018

Pharmaceutical Trademarks: A Global Guide 2018/2019

Mar – 27 -2018

Mexico Commercialisation of Healthcare

Feb – 20 2018

Life Sciences IP Review Bio 2017 edition

Jan – 25 -2018

 Practical Law’s Commercialisation of Healthcare Global Guide

Jan – 25 -2018

 Pharma 2018-2019

Jan – 2018

Getting the Deal Through: Life Sciences

Jan – 2018

Legal Q&A – Pharma Boardroom

Jan – 2018

Pharmaceutical IP and competition law in Mexico: overview
Aug-16-2017

IP rights protection and enforcement strategies for plant innovations in Mexico
Aug-15-2017

Commercialisation of Healthcare in Mexico: Overview
Aug-15-2017

Life Sciences: product regulation and liability in Mexico
Jun-14-2017

ICLG to: Pharmaceutical Advertising 2017
May-30-2017

Medicinal product regulation and product liability in Mexico: overview May 2017
May-15-2017

Pharma Boardroom Interview
Apr-03-2017

Cannabis and Narcotics for Medicinal use in Mexico
Mar-08-2017 — Article published in Pharma Boardroom http://pharmaboardroom.com/article/cannabis-and-narcotics-for-medicinal-use-in-mexico/

ICLG to: Pharmaceutical Advertising 2016
Jun-22-2016 — A practical cross-border insight into pharmaceutical advertising

Chapter 18 of TPP hits the Mexican life sciences industry
May-26-2016 — Some countries have transition periods for compliance with TPP requirements; in Mexico’s case, the transition periods are five years for regulatory data protection and four-and-a-half years for unreasonable curtailment of patent protection due to regulatory delays

Medicinal product regulation and product liability in Mexico: overview
Mar-03-2016

Chapter 18 of the TPP hits the life science industry in Mexico.
Feb-11-2016

Getting the Deal Through: Life Sciences 2016
Nov-03-2015

Latest developments in biologics and biosimiliar regulation
Oct-23-2015

Data protection exclusivity for biologics
Oct-08-2015

ICLG to: Pharma Advertising 2015
Jun-22-2015

Tightening the Customs Net
Jun-22-2015

Key issues for biotech products in mexico
Jun-08-2015

Pharmaceutical Law and Intellectual Property in Latin America
Apr-06-2015

Pharmaceutical Trademark Guide – Mexico 2015
Feb-17-2015

Getting the Deal Through: Life Science 2015
Feb-17-2015

Life Sciences – Multi-jurisdictional Guide 2013: Mexico
Feb-17-2015

Life Sciences – Multi-jurisdictional Guide 2014: Mexico
Feb-17-2015

Getting the Deal Through: Life Sciences 2014
Aug-25-2014

APIs, imports and the Bolar exemption: concerns and practical measures
Feb-04-2014

Current Conditions of Use Claims in the Pharmaceutical Sector in Mexico
Apr-01-2013

Crossed wires: protecting medicines in Mexico
Apr-01-2013

Life Sciences – Multi-jurisdictional Guide 2012: Mexico
Jun-20-2012

Maximising IP rights in the life sciences industry
Jun-08-2012

Latin America Roundtable
Sep-13-2011

New regulations pending
Sep-12-2011

The International Comparative Legal Guide to: Patents 2012
Sep-06-2011

Approval of follow-on biologics in Mexico
Jun-02-2011

Global Pharmaceutical Linkage Regulations: A Proposed Analytical Framework
May-04-2011

Life Sciences Handbook 2011 – Country Q&A
Mar-25-2011

Supreme Court upholds the worth of formulation patents
Jul-27-2010

Pharmaceutical Trademarks 2009
Jun-11-2010

Pharmaceutical Advertising 2008
Jun-11-2010

Framework for biotherapeutic products established
Jun-09-2010

Repercussions expected on medicine advertising campaign in Mexico
May-28-2010

Drugs Patent Reforms Introduced
Apr-01-2004